Sandra Orsulic
University of California, Los Angeles
H-index: 53
North America-United States
Top articles of Sandra Orsulic
Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma
Science Advances
2024/4/17
Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas
Nature Communications
2024/3/20
Sandra Orsulic
H-Index: 34
INHBA (+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer
NPJ Precision Oncology
2024/2/15
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
The Journal of Pathology: Clinical Research
2023/5
Metabolic dependencies and targets in ovarian cancer
2023/4/13
Yaqi Zhang
H-Index: 6
Yinu Wang
H-Index: 7
Guangyuan Zhao
H-Index: 6
Sandra Orsulic
H-Index: 34
Daniela Matei
H-Index: 7
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
Cancer
2023/3/1
Abstract B054: Immunological control by PARP inhibitors for successful immunotherapy in metastatic ovarian carcinoma
Cancer Immunology Research
2023/12/1
Sandra Orsulic
H-Index: 34
Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
medRxiv
2023/11/10
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study
British journal of cancer
2023/1/26
1432 Cancer-associated fibroblasts metabolic targeting overcomes T-cell exclusion and chemoresistance
2023/11/1
Sandra Orsulic
H-Index: 34
Ciliated cell markers in epithelial ovarian cancer: Associations with histologic subtype, stage, and disease progression (2266)
Gynecologic Oncology
2023/9/1
Sandra Orsulic
H-Index: 34
Tumor-Associated Macrophages Expand Chemoresistant, Ovarian Cancer Stem-Like Cells
bioRxiv
2023/7/19
Gene-expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes
Clinical Cancer Research
2022/12/15
Matthew Wakefield
H-Index: 10
Ian Campbell
H-Index: 2
Joshua Cohen
H-Index: 17
Anna Fischer
H-Index: 28
Anna Jakubowska
H-Index: 9
Jae-Weon Kim
H-Index: 40
Jae-Hoon Kim
H-Index: 1
Na Li
H-Index: 5
David Morris
H-Index: 10
Sandra Orsulic
H-Index: 34
Celeste Leigh Pearce
H-Index: 37
Deepak Subramanian
H-Index: 6
Martin Köbel
H-Index: 48
Ciliated Cells in Ovarian Cancer Decrease with Increasing Tumor Grade and Disease Progression
Cells
2022/12/11
Sandra Orsulic
H-Index: 34
Dynamic changes in the extracellular matrix in primary, metastatic, and recurrent ovarian cancers
Cells
2022/11/25
Molecular pathology and computational image analyses in gynecologic malignancies
Frontiers in Oncology
2022/11/21
Umberto Malapelle
H-Index: 28
Sandra Orsulic
H-Index: 34
Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids
Proceedings of the National Academy of Sciences
2022/10/11
FOXC2 promotes vasculogenic mimicry in ovarian cancer
Cancers
2022/10/4
Sandra Orsulic
H-Index: 34
Focal serous tubal intra-epithelial carcinoma lesions are associated with global changes in the fallopian tube epithelia and stroma
Frontiers in Oncology
2022/3/21
Yael Raz
H-Index: 11
Sandra Orsulic
H-Index: 34
Co-Authors
